Search
for
Sort by
Research 91–120 of 1000+
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Patient preferences in the treatment of alopecia areata: A review of the literature
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Hair
- Treatments for alopecia areata: a network meta-analysis
- Real-world evidence in alopecia areata treatment: A narrative review
- Autoinmune Alopecia/Alopecia Areata
- Alopecia areata: current concepts
- Under Development JAK Inhibitors for Dermatologic Diseases
- Janus kinase inhibitors for alopecia areata: A narrative review
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Unlocking the Potential of Rosemary in Alopecia: A Narrative Review of Evidence on Mechanism, Applications and Challenges
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Az alopecia areata kezelésében alkalmazott baricitinib hatásosságának és biztonságosságának retrospektív vizsgálata = Efficacy and safety of baricitinib treatment in alopecia areata:a retrospective analysis
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review